• Copper Banking

  Participated · Seed · Oct 2021

  Copper operates a consumer platform that lets users earn through mobile games, cash back on everyday shopping, and other digital activities — including in-store purchases. The company reports more than 4 million members and says it is building a proprietary dataset of consumer purchase behavior and engagement patterns across online and offline activity. Copper has raised $42 million from leading, tier-one investors and was ranked the #2 fastest-growing company in the Pacific Northwest on the Deloitte Technology Fast 500 based on three-year revenue growth. The company positions itself at the intersection of entertainment, commerce, and financial utility and aims to be a central platform for product discovery and earnings. The announcement notes a new investment from Diplo but does not disclose the amount or specific use of proceeds.

• Vivli

  Led · Equity · Oct 2017

  Launched in 2016 as a not-for-profit 501(c)(3) based in Cambridge, Mass., Vivli is building a global clinical research data-sharing platform. The platform's central feature is a powerful search engine that allows researchers to make one combined data request for multiple datasets. Once requests are approved, researchers can combine and analyze datasets within the Vivli platform using integrated statistical tools. Vivli says the recently secured funding will complete the platform's initial build and support infrastructure and operations through launch and beyond. The organization intends to expand services and to support and amplify existing data repositories by making datasets easier to find and analyze, with the goal of accelerating medical research. Vivli is a Massachusetts-based nonprofit (launched in 2017) that is developing a first-of-its-kind platform to aggregate and share clinical trial data. The platform will include a data repository, analysis tools, and a dynamic search engine to break data out of existing silos. Vivli intends to provide transparency and access to clinical research data worldwide, enabling public and private institutions to combine datasets at the individual patient level. The service aims to accelerate scientific discovery, optimize time and financial resources spent on research, and unearth new insights to improve human health. The organization frames its mission around advancing human health through data sharing while respecting contributions of clinical research participants. With philanthropic support, Vivli planned to move to launch the platform in 2018.

• Make.TV

  Participated · Equity · Jun 2017

  Make.TV's core product is the Live Video Cloud (LVC), a cloud-based live video acquisition and management platform that ingests and curates unlimited live and near-live sources including mobile devices and social platforms. The platform enables broadcasters and publishers to monitor incoming feeds, communicate with contributors, and route programming to broadcast channels, social networks and OTT endpoints. Make.TV cites customers across media and technology—including ESL, BAMTech/MLB, Viacom, FOX Sports Brasil, RTL2, SWR, BR and Swiss public broadcaster SRF—using LVC for eSports, mobile and traditional live video. The company positions LVC as a solution for acquiring and circulating user-generated content as well as professionally produced streams. Proceeds from the financing will be used to accelerate product development, marketing and global sales efforts. Make.TV maintains offices in Seattle and Cologne and is expanding its U.S. and engineering/customer-support footprint.

• Science Exchange

  Led · Grant · Oct 2013

  Science Exchange operates a SaaS-enabled marketplace that gives enterprise R&D teams instant access to a network of pre-qualified scientific service providers, including CROs, CMOs, and academic labs. The platform combines marketplace access with contracting, project management, and reporting tools to streamline outsourced R&D. It reports immediate access to over 3,000 service providers and serves more than 100 enterprise customers. The company says the platform increases scientist productivity by removing administrative barriers and consolidating R&D outsourcing spend. Science Exchange plans to use new funding to further develop its software platform and expand its footprint in the biotech and pharmaceutical market. Since founding in 2011, the company has raised in excess of $70 million from a group of investors named in the article. Science Exchange operates a marketplace platform that gives researchers access to more than 2,500 outsourced R&D service providers, including CROs, CMOs, academic labs and government facilities. Thousands of scientists, including users from 10 of the top 20 biopharma companies, have used the platform to support scientific research. The company also offers an enterprise program to help organizations consolidate R&D outsourcing spend. Science Exchange plans to use the new funds to expand beyond biopharma into agrosciences, cosmetics, aerospace and industrial chemicals, and to hire across product, engineering, sales, marketing and customer success. Financially, the company raised $28M in a Series C and has raised more than $58 since its inception in 2011. Elizabeth Iorns, Ph.D., leads the company as CEO. Science Exchange operates an online marketplace that connects academic, government, and industry researchers with third‑party laboratory service providers. The platform lets customers order outsourced lab services through its site and claims more than 2,500 institutions on the demand side. Over the last year the company has pushed into big pharma—working with Sanofi—and reports 500% growth. It says eight of the top 10 pharmaceutical companies use the platform, and that enterprise orders are roughly an order of magnitude larger than academic orders (academic orders average $3,000–$5,000). The startup plans to use new funding to hire across product, engineering, sales, marketing, and customer success and to expand into additional top research institutions in the U.S. and Europe. It also intends to pursue research categories such as food tech and cosmetics. Science Exchange operates the Reproducibility Initiative, created with PLOS, figshare, and Mendeley, to provide a mechanism for independent replication and to reward scientists who reproduce findings. The initiative has validated more than 1,000 antibodies for antibodies-online and is expanding into cancer biology validation. The organization received a $1.3 million grant from the Laura and John Arnold Foundation to validate 50 landmark cancer biology studies. Elizabeth Iorns, cofounder and CEO, launched the effort after experiencing irreproducible results during her prior breast cancer research. The funding is intended both to verify influential cancer studies and to help institutionalize scientific replication practices. Science Exchange is a community marketplace that lets research scientists list, discover, access and pay for outsourced scientific services from institutions around the world. The platform allows scientists to search for experiment types, view and compare providers, and choose a provider to work with. The company was co-founded in May 2011 by Elizabeth Iorns Ph.D. (CEO), Ryan Abbott (Technical), and Dan Knox (Product, Operations) and is based in Palo Alto, CA. Science Exchange raised $3M in a Series A financing led by Union Square Ventures, with participation from O’Reilly Alpha Tech Ventures and multiple angel and existing investors. In conjunction with the funding, USV partner Andy Weissman joined the company’s board. The company will use the funds to expand its engineering team and to grow its marketplace by adding solutions in new scientific disciplines, including bio-chemistry and clinical services, over the coming year.

No current team members are available.